IFCI shares surge 30% in 3 days on NSE IPO filing buzz

IFCI's core business remains under pressure. The company reported a net loss of ₹120 crore for the December quarter, its fourth straight quarterly loss, as provisions against bad loans stayed elevated. Its gross non-performing asset ratio stood at 18.5% as of December.

The NSE stake is the single most valuable asset on IFCI's books. A successful IPO of that holding would give the company a cash infusion that could be used to pare debt or shore up capital adequacy. IFCI's capital adequacy ratio was 14.2% at end-December, above the regulatory minimum of 12% but below the 16% level that rating agencies consider comfortable for its risk profile.

For traders, the setup is straightforward: the stock is moving on a catalyst that has a defined timeline. If the DRHP is filed by Thursday as expected, the next milestone will be Sebi's approval, which typically takes three to six months. If the filing is delayed, the stock could give back some of the recent gains.

The NSE IPO itself has been a long-running story. The exchange filed for a listing in 2017 but the process stalled amid regulatory scrutiny of its governance and the co-location controversy. A fresh filing would revive the listing timeline, though Sebi's approval is not guaranteed.

IFCI's Alpha Score on AlphaScala is 40 out of 100, with a Mixed label, reflecting the tension between the asset-sale catalyst and the weak core business. The stock page is here.

For now, the market is pricing the NSE stake as a near-term event. The next few trading sessions will show whether the filing materializes on schedule.